News
For all media enquiries email us at [email protected] or call 0478 854 644.

The results from a multi-site Australian trial, investigating the effects of long-acting injectable ‘depot’ buprenorphine treatment in people experiencing opioid addiction, have today been released.

Rethink Addiction is holding its first major event on Thursday 6th May called 'Rethinking Addiction in Australia'. As a proud partner of the Rethink Addiction campaign, Turning Point is thrilled to be supporting this very exciting event.

Turning Point and Monash Addiction Research Centre welcome the opportunity to present to the ‘Inquiry into use of Cannabis in Victoria’.

This week we celebrate International Women's Day, and while the occasion is an opportunity to celebrate female achievements, it also highlights the many inequalities women still face. Our Deputy Clinical Director of Treatment Services, Dr Shalini Arunogiri, writes about the barriers women encounter when it comes to addiction and treatment, and how a Turning Point program is helping women find their voice.

Today is a historic day with the tabling in Parliament of the final report and recommendations of the Royal Commission into Victoria’s Mental Health System.

Researchers at Turning Point and Monash University are looking for Victorian participants to take part in this survey, with the chance to win one of twenty $50 Coles vouchers.

It was a privilege to work with the participants and their loved ones during filming and to share on screen the positive changes they were able to achieve.

Professor Dan Lubman has been appointed a Member of the Order of Australia (AM) for significant service to medical education, research, treatment and policy in the field of addiction.

For many people, January is a time for setting New Year’s goals or resolutions. If managing your gambling, alcohol or other drug use is something you want to achieve in 2021, here are some tips to help you get started or stay on track.

A new study by researchers from Monash University & Turning Point has shown that women and people with mental health issues are more likely to require attendance by an ambulance for oxycodone misuse.

In times of crisis we often turn to alcohol or other drugs to help us cope, so it's not surprising that one in four Australians will develop an alcohol, drug [or gambling] disorder during their lifetime and around one in 20 will develop an addiction. As a society however, we often assign blame to the individual and don't consider the factors that contribute to someone developing an addiction.

During COVID-19, people receiving treatment for opioid use disorder in Australia faced significant challenges. Over 500,000 Australians access buprenorphine or methadone medication treatment programmes nationally, which usually involves seeing a doctor once a month, and attending a pharmacy several times a week to collect medication, alongside counselling and peer supports. The pandemic lockdown restrictions posed real challenges to access.